PE20140917A1 - Sintesis de derivados de 2-carboxamida-cicloamino-urea - Google Patents

Sintesis de derivados de 2-carboxamida-cicloamino-urea

Info

Publication number
PE20140917A1
PE20140917A1 PE2013002003A PE2013002003A PE20140917A1 PE 20140917 A1 PE20140917 A1 PE 20140917A1 PE 2013002003 A PE2013002003 A PE 2013002003A PE 2013002003 A PE2013002003 A PE 2013002003A PE 20140917 A1 PE20140917 A1 PE 20140917A1
Authority
PE
Peru
Prior art keywords
formula
compound
solvent
producing
contact
Prior art date
Application number
PE2013002003A
Other languages
English (en)
Inventor
Bernhard Erb
Isabelle Sylvie Gallou
Florian Karl Kleinbeck
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=45787206&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PE20140917(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of PE20140917A1 publication Critical patent/PE20140917A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/26Radicals substituted by halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/06Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
    • C07D213/16Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing only one pyridine ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

SE REFIERE A UN PROCESO PARA LA ELABORACION DE UN COMPUESTO DE FORMULA (X) QUE COPRENDE: A) PONER EN CONTACTO EL COMPUESTO DE FORMULA (I) CON UN SOLVENTE TAL COMO UN SOLVENTE AROMATICO, ALIFATICO, HALOGENADO, ENTRE OTROS Y UNA BASE TAL COMO DI-ISOPROPIL-AMIDA DE LITIO, LUEGO PONER EN CONTACTO LA MEZCLA RESULTANTE CON EL COMPUESTO DE FORMULA (II) PRODUCIENDOSE EL COMPUESTO DE FORMULA (III); B) PONER EN CONTACTO EL COMPUESTO DE FORMULA (III) CON TIOUREA, EN UNA MEZCLA DE REACCION QUE COMPRENDE UN SOLVENTE Y UN AGENTE OXIDANTE TAL COMO REACTIVO DE HALOGENO ELECTROFILICO, PRODUCIENDOSE EL COMPUESTO DE FORMULA (V); C) PONER EN CONTACTO LOS COMPUESTOS DE FORMULA (V) Y (VII), EN UNA MEZCLA DE REACCION QUE COMPRENDE UN SOLVENTE Y UNA BASE TAL COMO PIRIDINA, PRODUCIENDOSE EL COMPUESTO DE FORMULA (VIII); Y D) PONER EN CONTACTO LOS COMPUESTOS DE FORMULA (VIII) Y (IX) EN UNA MEZCLA DE REACCION QUE COMPRENDE UN SOLVENTE, PRODUCIENDOSE EL COMPUESTO DE FORMULA (X). R1 ES UN ALQUILO C1-C7 CICLICO O ACICLICO, RAMIFICADO O LINEAL OPCIONALMENTE SUSTITUIDO; R2 ES H, FLUOR, Cl, METILO OPCIONALMENTE SUSTITUIDO
PE2013002003A 2011-03-03 2012-03-01 Sintesis de derivados de 2-carboxamida-cicloamino-urea PE20140917A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201161448774P 2011-03-03 2011-03-03

Publications (1)

Publication Number Publication Date
PE20140917A1 true PE20140917A1 (es) 2014-08-14

Family

ID=45787206

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2013002003A PE20140917A1 (es) 2011-03-03 2012-03-01 Sintesis de derivados de 2-carboxamida-cicloamino-urea

Country Status (32)

Country Link
US (3) US9650373B2 (es)
EP (1) EP2681192B1 (es)
JP (1) JP6022485B2 (es)
KR (1) KR101851421B1 (es)
CN (2) CN103402982B (es)
AR (2) AR088714A1 (es)
AU (1) AU2012222346B2 (es)
BR (1) BR112013021882A2 (es)
CA (1) CA2828509C (es)
CL (1) CL2013002521A1 (es)
CO (1) CO6751286A2 (es)
DK (1) DK2681192T3 (es)
EA (4) EA201892052A1 (es)
EC (1) ECSP13012914A (es)
ES (1) ES2663717T3 (es)
GT (1) GT201300211A (es)
HU (1) HUE036319T2 (es)
IL (1) IL228023A (es)
MA (1) MA34982B1 (es)
MX (2) MX347348B (es)
MY (1) MY163214A (es)
NO (1) NO2681192T3 (es)
PE (1) PE20140917A1 (es)
PL (1) PL2681192T3 (es)
PT (1) PT2681192T (es)
SG (1) SG192793A1 (es)
SI (1) SI2681192T1 (es)
TN (1) TN2013000354A1 (es)
TW (2) TWI607994B (es)
UA (1) UA112539C2 (es)
WO (1) WO2012117071A1 (es)
ZA (1) ZA201306174B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA112539C2 (uk) * 2011-03-03 2016-09-26 Новартіс Аг Спосіб одержання похідних 2-карбоксамідциклоаміносечовини
CN111704543A (zh) * 2014-11-14 2020-09-25 燿石治疗公司 用于制备α,ω-二羧酸封端的二烷醚的方法和中间体
JP7014737B2 (ja) 2017-01-20 2022-02-01 株式会社ペーターズ スケートボード用ハンドル及びハンドル付きスケートボード
CN112961090A (zh) * 2019-12-13 2021-06-15 武汉九州钰民医药科技有限公司 合成Alpelisib的关键中间体及其制备方法
CN111057051A (zh) * 2019-12-16 2020-04-24 武汉九州钰民医药科技有限公司 PI3K抑制剂Alpelisib的新合成方法
CN110964005A (zh) * 2019-12-16 2020-04-07 武汉九州钰民医药科技有限公司 一种Alpelisib的制备工艺
KR20220125753A (ko) 2021-03-05 2022-09-14 배성륭 기능성 풍력 발전시스템

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3534056A (en) * 1967-03-02 1970-10-13 Pennwalt Corp Fluoro-alkyl pyridines and their preparation
UA60365C2 (uk) 1998-06-04 2003-10-15 Пфайзер Продактс Інк. Похідні ізотіазолу, спосіб їх одержання, фармацевтична композиція та спосіб лікування гіперпроліферативного захворювання у ссавця
PL355639A1 (en) 1999-09-10 2004-05-04 Merck & Co, Inc. Tyrosine kinase inhibitors
AR044519A1 (es) * 2003-05-02 2005-09-14 Novartis Ag Derivados de piridin-tiazol amina y de pirimidin-tiazol amina
US8455658B2 (en) 2006-01-25 2013-06-04 Synta Pharmaceuticals Corp. Thiazole and thiadiazole compounds for inflammation and immune-related uses
TWI428091B (zh) 2007-10-23 2014-03-01 Du Pont 殺真菌劑混合物
PE20091523A1 (es) 2007-12-20 2009-10-29 Novartis Ag Derivados de tiazol como inhibidores de la enzima fosfatidilinositol 3-cinasa (pi3k)
EP2235983B1 (en) * 2007-12-21 2011-07-20 Telefonaktiebolaget LM Ericsson (publ) Method, apparatus and computer program for handover from a first access point to a second access point
UA104147C2 (uk) * 2008-09-10 2014-01-10 Новартис Аг Похідна піролідиндикарбонової кислоти та її застосування у лікуванні проліферативних захворювань
UA112539C2 (uk) * 2011-03-03 2016-09-26 Новартіс Аг Спосіб одержання похідних 2-карбоксамідциклоаміносечовини

Also Published As

Publication number Publication date
MX2013010132A (es) 2013-10-30
HUE036319T2 (hu) 2018-06-28
AR088714A1 (es) 2014-07-02
AU2012222346B2 (en) 2015-05-07
MY163214A (en) 2017-08-30
EA201691331A1 (ru) 2017-01-30
EP2681192B1 (en) 2017-12-27
JP6022485B2 (ja) 2016-11-09
EP2681192A1 (en) 2014-01-08
US20170355677A1 (en) 2017-12-14
US20170240509A1 (en) 2017-08-24
TWI597279B (zh) 2017-09-01
US9776966B2 (en) 2017-10-03
CN103402982A (zh) 2013-11-20
EA025381B1 (ru) 2016-12-30
CO6751286A2 (es) 2013-09-16
ECSP13012914A (es) 2013-11-29
DK2681192T3 (en) 2018-04-16
US10059670B2 (en) 2018-08-28
BR112013021882A2 (pt) 2016-07-19
EA201892052A1 (ru) 2019-02-28
US9650373B2 (en) 2017-05-16
IL228023A0 (en) 2013-09-30
KR20140009432A (ko) 2014-01-22
WO2012117071A1 (en) 2012-09-07
EA201792068A2 (ru) 2018-01-31
ES2663717T3 (es) 2018-04-16
SG192793A1 (en) 2013-09-30
TN2013000354A1 (en) 2015-01-20
CL2013002521A1 (es) 2014-02-14
EA201792068A3 (ru) 2018-05-31
KR101851421B1 (ko) 2018-04-23
JP2014511387A (ja) 2014-05-15
TW201247660A (en) 2012-12-01
IL228023A (en) 2017-04-30
SI2681192T1 (en) 2018-04-30
CN103402982B (zh) 2016-07-13
EA201391267A1 (ru) 2014-01-30
ZA201306174B (en) 2014-05-28
AU2012222346A1 (en) 2013-08-29
TW201722916A (zh) 2017-07-01
GT201300211A (es) 2014-12-30
CN106083840A (zh) 2016-11-09
TWI607994B (zh) 2017-12-11
CA2828509A1 (en) 2012-09-07
UA112539C2 (uk) 2016-09-26
PT2681192T (pt) 2018-04-02
US20130331579A1 (en) 2013-12-12
NO2681192T3 (es) 2018-05-26
EA032802B1 (ru) 2019-07-31
PL2681192T3 (pl) 2018-06-29
CA2828509C (en) 2018-11-20
AR123584A2 (es) 2022-12-21
NZ614173A (en) 2015-04-24
CN106083840B (zh) 2020-01-03
MX347348B (es) 2017-04-17
MA34982B1 (fr) 2014-03-01
MX351740B (es) 2017-10-26

Similar Documents

Publication Publication Date Title
PE20140917A1 (es) Sintesis de derivados de 2-carboxamida-cicloamino-urea
AR088483A1 (es) Proceso para preparar derivados de quinolina
AR089539A1 (es) Metodos de formacion de esteres pinacolicos de acido 4-cloro-2-fluoro-3-sustituido-fenilboronico y sus metodos de uso
BR112015015031A2 (pt) processo de glicoconjugação
PE20141066A1 (es) Compuestos de benzotiazol
DOP2010000267A (es) Compuesto heterociclico
CO6640226A2 (es) 5-fluoro-1h-pirazolipiridinas sustituidas y su uso
AR095443A1 (es) Heterociclos condensados con acción sobre atr
AR088564A1 (es) PROCESO PARA LA PREPARACION DE AGONISTAS Y COMPUESTOS INTERMEDIOS DE b3
CR20130543A (es) Derivados de pirrolotriazinona como inhibidores de pi3k
AR061739A1 (es) Nuevos derivados naftalenicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen
CR20130616A (es) Amidas-2-piridina útiles como agonistas cb2
CO7111275A2 (es) Inhibidores de dgat1 de éter cíclico de cabeza de puente
EA201691102A1 (ru) Способ удаления soиз газа при помощи полиольного сложного раствора
AR083903A1 (es) Derivados de benzooxazol y benzotiazol sulfonamidas, utiles para tratar trastornos del ritmo cardiaco y cancer, composiciones farmaceuticas que los contienen y metodo para prepararlos
CR20140139A (es) Método para formar un muro de contención y muro de contención correspondiente
AR086837A1 (es) Moduladores heterociclicos de sintesis lipidica
UY32004A (es) Derivados de carbamatos de alquiltiazoles, su preparación y su aplicación en terapéutica
UY35332A (es) Derivados de pirrolotriazina como inhibidores de pi3k
BR112013016637A2 (pt) processo para a preparação de derivados de 3-alquil-sulfinilbenzoíla
AR092355A1 (es) Fluoruros de fluoropicolinoilo y procesos para su preparacion
AR094954A1 (es) Preparación de 1,3-(diarilo sustituido)-1,2,4-triazoles e intermediarios derivados de ellos
PA8789601A1 (es) Proceso para la preparación de trifluoralquil-fenil sulfonamidas y de sulfonamidas heterocíclicas
EA201401277A1 (ru) Соединения метантиона, обладающие противовирусной активностью
AR084590A1 (es) Composicion de control de plagas de artropodos y metodo de control de plagas de artropodos

Legal Events

Date Code Title Description
FG Grant, registration
FD Application declared void or lapsed